Xiang Cui

Dr. Xiang Cui

Peking Union Medical College and Chinese Academy of Medical Sciences
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2020 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
ZHZhiliang Hu
Zhiliang Hu
YLYanling Lv
Yanling Lv
CXChuanjun Xu
Chuanjun Xu
WSWenkui Sun
Wenkui Sun
WCWei Chen
Wei Chen
YYYongxiang Yi
Yongxiang Yi
Background: The emerging coronavirus disease 2019 (COVID-19) has become a serious public health concern with a high number of fatalities. It is unclear whether corticosteroids could be a candidate for an early intervention strategy for patients with COVID-19. Methods: In this retrospective cohort study, we analyzed data from 28 corticosteroid-treated patients with non-severe but advanced COVID-19, in which short-course and low-dose corticosteroids were administered because of unremitting or worsening clinical conditions during hospitalization. To compare the effect of corticosteroids on viral clearance, 44 corticosteroid-untreated patients were included as controls. Results: At the time of admission, corticosteroid-treated patients (n = 28) had a more advanced baseline illness compared with corticosteroid-untreated patients (n = 44), as reflected by poorer blood laboratory parameters (lymphocytes, C-reactive protein, and lactate dehydrogenase) and more extensive chest computed tomography (CT) abnormalities. Corticosteroids were given because of radiological evidence of pneumonia progression (26/28) and/or unremitting fever (22/28) after admission. The median time from illness onset to corticosteroid treatment was 9 days (IQR, 7–10). The median duration and accumulated dose of corticosteroid treatment were 4.5 days [interquartile range (IQR), 3–5] and 140 mg of methylprednisolone (IQR, 120–200). Intravenous immunoglobulin (20 g per day for 3–5 days) was co-administered with corticosteroids. With the corticosteroid treatment, all patients achieved an abatement of fever within 1 day, and 78.6% (22/28) of the patients achieved radiological remission when evaluated about 3 days later. Only one (3.6%) patient progressed to severe COVID-19, and all patients recovered and were discharged without any sequela. The median time from illness onset to viral clearance was similar, as compared with 44 corticosteroid-untreated patients with relatively milder disease [18 (IQR 14.3–23.5) days vs. 17 (IQR, 12–20) days, p = 0.252]. When adjusted for age, sex, underlying comorbidities, baseline blood laboratory parameters, viral load, and chest radiological findings, the causal hazard ratio of corticosteroid treatment for the viral clearance was 0.79 (95%CI, 0.48–1.30, p = 0.34). Conclusion: Short-course and low-dose applications of corticosteroids, when co-administered with intravenous immunoglobulin, in non-severe COVID-19 patients during the stage of clinical deterioration may possibly prevent disease progression, while having a negligible impact on the viral clearance.

1 January 2021 in Chinese Journal of Cancer Research
Verified
Journal Article
Open access
YCYue Cai
Yue Cai
WCWanqing Chen
Wanqing Chen
XWXiaoxu Wang
Xiaoxu Wang
XXXue Xia
Xue Xia
XCXiang Cui
Xiang Cui
JLJinghua Li
Jinghua Li
ObjectiveTo describe the contemporary trends in total, inpatient, and outpatient expenditure on major subtypes of cancer in different classifications of hospitals in mainland China. MethodsHome page of Inpatient Medical Records (HIMRs) and Hospital Annual Reports (HARs) were used to estimate hospital care expenditure on cancer. Inpatient payments and their share of cancer were calculated with the top-down method. Kriging spatial interpolation methods were used at the county level and summed at the province level. Outpatient expenditure was estimated with inpatient expenditure and the ratios of outpatient to inpatient payments in specialized cancer hospitals, stratified by province. Total expenditure on cancer was the sum of both payments. Log-linear regression was applied to estimate annual percentage change (APC) of expenditure. ResultsTotal expenses for cancer of Chinese residents reached up to 304.84 billion Chinese Yuan (CNY) in 2017, accounting for 5.8% of the total health expenses (THE). After adjusting for consumer price index (CPI), medical expenses for cancer have increased from 63.30 billion CNY in 2008 to 249.56 billion CNY in 2017 [APC: 15.2%, 95% confidence interval (95% CI): 13.4%−17.0%]. The APC was slightly higher than THE around 2013, while was lower after 2013. During 2008−2017, the ratio of inpatient to outpatient costs for cancer decreased from 4.3:1 to 3.8:1. The inpatient payments for cancer mainly happened in grade 3 general hospitals, East China, and among lung, colorectal, and stomach cancer; while the fastest increase was found in West China, and among thyroid, prostate, and colorectal cancer. ConclusionsDuring 2008−2017, the rapid growth trend of medical expenses for cancer has been effectively controlled with the continuous deepening of medical reform and improvements of residents’ health care. More attention should be paid to potential increases of medical costs caused by technological progress and demand release. Socialized and multi-channel insurance financing modes should be explored in the future.

6 September 2020 in BMJ Open
Verified
Journal Article
Open access
PDF file
JJJiayi Jiang
Jiayi Jiang
MZMingyi Zhang
Mingyi Zhang
HMHaojie Meng
Haojie Meng
XCXiang Cui
Xiang Cui
YYYuxin Yang
Yuxin Yang
LZLuqing Zhang
Luqing Zhang
Objectives To investigate the demographics and motivations of whole-body donors in China, and help suggest a solution to the problem of low body donation numbers. Design A cross-sectional study on body donors in China. Demographic analysis of the donating information of deceased donors and in-depth interviews of potential body donors. Setting Eleven districts in Nanjing, China. Participants Deceased whole-body donors who had donated their bodies to the body donation receiving station of Nanjing Medical University between 1 July 2009 and 30 June 2019 (n=835), and living registered whole-body donors (n=68). Results Among the whole-body donor population, the numbers of males, people older than 65 years and those working as teachers, government officials, medical staff and farmers were significantly higher than those of the general Nanjing population. Donors with an education level of college or above accounted for nearly half of the deceased donors, and considered donating their bodies earlier in their lives than others. Cancer and heart disease were the major causes of death among donors. Interviews of the 68 living donors revealed the following major motivations for the decision to donate: to support medical education; to reduce their children’s funeral burden; no longer holding traditional Chinese views on life and death; influence by role models and annoyance at complex funeral ceremonies. Conclusions Older people, people with an education level of college or above, labourers, teachers, government officials and farmers are the major groups that donate their bodies. Although people’s motivations for donation are complex, their desire to support medical education is the most prevalent motivation. By helping focus on target groups for promotional messaging and identifying their prime motivations, this study’s findings can provide a reference for promoting body donation in China.

27 February 2020 in Preprints.org
Verified
Preprint
Open access
PDF file
GCGuoshuai Cai
Guoshuai Cai
XCXiang Cui
Xiang Cui
XZXia Zhu
Xia Zhu
JZJun Zhou
Jun Zhou
The current spreading novel coronavirus SARS-CoV-2 is highly infectious and pathogenic and has attracted global attention. Recent studies have found that SARS-CoV-2 and SARS-CoV share around 80% of homology and use the same cell entry receptor, ACE2. These inspired us to study other receptors of SARS-CoV, which may be used for SARS-CoV-2 binding as well. In this study, we screened the gene expression of three receptors (ACE2, DC-SIGN and L-SIGN) in four datasets of normal lung tissue from lung adenocarcinoma patients and two single-cell RNA sequencing datasets from normal lung and bronchial epithelial cells separately. No significant difference in gene expression of these three receptors were found between gender groups (male vs female). We found higher gene expression of DC-SIGN in elder with age>60 and higher gene expression of L-SIGN in Caucasian than Asian. Similar to ACE2, we observed significantly higher DC-SIGN gene expression in the lungs of smokers, especially former smokers. However, smokers upregulate ACE2 and DC-SIGN gene expression in different cell types. In the whole lung, ACE2 is actively expressed in remodeled Alveolar Type II cells of former smokers, while DC-SIGN is largely expressed in monocytes of former smokers and dendritic cells of current smokers. In bronchial epithelium, no obvious gene expression of DC-SIGN and L-SIGN was observed while ACE2 was found to be actively expressed in goblet cells of current smokers and club cells of non-smokers. In conclusion, our findings may indicate that smokers, especially former smokers, and people over 60 have higher risk and are more susceptible to SARS-CoV-2 infection. Also, this study provides hints on possible SARS-CoV-2 pathogenicity mechanisms in lung infection.

1 October 2018 in Translational Cancer Research
Verified
Journal Article
Closed access
PDF file
YLYao Li
Yao Li
BHBao-Quan Hu
Bao-Quan Hu
XWXiu-Juan Wu
Xiu-Juan Wu
XQXiaowei Qi
Xiaowei Qi
JJJun Jiang
Jun Jiang
XYXinhua Yang
Xinhua Yang
Background: For a long period of time, the Mediterranean diet (MD) has been regarded by many as a very healthy and balanced daily diet that may be related to the incidences of many types of cancer. However, the association between an MD and breast cancer risk remains inconsistent even though many studies about the topic have been conducted. Hence, we performed a meta-analysis to evaluate the relationship between an MD and breast cancer risk. Methods: We searched PubMed, Medline, and EMBASE for relevant articles published earlier than May 2017. “Mediterranean diet” combined with “breast cancer” and “breast carcinoma” were used as search terms. The combined relative risk (RR) and corresponding 95% confidence interval (CI) were used to evaluate the association between an MD and breast cancer risk. Results: A total of 18 articles were included in our meta-analysis; the studies spanned 11 years, ranging from 2006 to May 2017. Ten cohort and 8 case-control studies were included. Seven studies analyzed breast cancer incidence separately in premenopausal and postmenopausal women, whereas 6 studies were performed only in postmenopausal women, for a total of 13 analyses in postmenopausal women and 7 analyses among premenopausal women. Our meta-analysis revealed a significant and inverse association of the MD and breast cancer risk (RR: 0.92, 95% CI: 0.86, 0.99). Stratification analysis by study design and menopause status revealed a significant inverse association between the MD and breast cancer risk in case-control studies (RR: 0.85, 95% CI: 0.73, 0.99) and postmenopausal women (RR: 0.91, 95% CI: 0.85, 0.97) but not in cohort studies and premenopausal women. Conclusions: Our meta-analysis revealed that an MD is significantly associated with a reduction of breast cancer risk in women, especially postmenopausal women. The MD can be suggested to women, especially postmenopausal women, as a healthy diet to reduce breast cancer risk.

28 January 2026 in European Journal of Preventive Cardiology
Verified
Journal Article
Closed access
CYChenxi Yuan
Chenxi Yuan
TZTao Zhou
Tao Zhou
XCXiang Cui
Xiang Cui
SXShaohua Xie
Shaohua Xie
XLXiangfeng Lu
Xiangfeng Lu
FLFangchao Liu
Fangchao Liu
Aims: As ‘one-size-fits-all’ physical activity (PA) recommendations are increasingly challenged, the optimal PA patterns across different predicted cardiovascular disease (CVD) risk populations remain unclear. This study aimed to identify the optimized PA patterns for different risk populations, thereby refining current recommendations. Methods and results: We conducted a prospective cohort study involving 72 884 participants from the UK Biobank. Individuals with accelerometer-derived total volume of PA (TPA), moderate-intensity PA (MPA), vigorous-intensity PA (VPA), moderate-to-vigorous PA (MVPA), and sedentary time were categorized into low-to-moderate-, high-, or very high-risk groups by the updated Systemic Coronary Risk Estimation 2 (SCORE2), SCORE2-Older Persons, and SCORE2-Diabetes. Cox regressions and compositional data analysis modelled associations between PA and incident CVD and potential benefits of reallocating sedentary time to MVPA. An inverse association between TPA, as well as MVPA, and incident CVD was observed, with very high-risk populations benefiting most, showing a 20% (95% CI 14–26%) lower hazard for each 150-min/week increase in MVPA, compared with 16% (14–18%) in high-risk and 16% (13–19%) in low-to-moderate-risk individuals (Pinteraction < 0.0001). Further analyses suggested MVPA recommendations should be tailored to individual risk stratifications. For low-to-moderate-risk individuals, replacing 300 min/week of sedentary time with any MVPA combination provided benefits. However, high-risk and very high-risk individuals should limit their VPA to 60 and 42 min/week, respectively, beyond which benefits may diminish. Conclusion: The optimal VPA threshold should be underscored, especially for high- or very high-risk populations. This study advocates personalized PA recommendations by integrating risk assessment to maximize cardioprotective effects while minimizing potential harms.